The Charles R. Ream, MD, Award for Excellence—2006  by Walson, Judd L.
67
C U R R E N T T H E R A P E U T I C R E S E A R C H
V O L U M E 68,  N U M B E R 2 ,  M A R C H /A P R I L 2007
Announcement
The Charles R. Ream, MD, Award for 
Excellence—2006
The editorial board of Current Therapeutic Research is pleased to announce the
selection of the seventh annual Charles R. Ream, MD, Award for Excellence.
This year’s selection was particularly difficult given the wide range of articles
that the editorial board selected as nominees. The incredible diversity of nom-
inees is a testament to the quality of many of the articles published in the jour-
nal in 2006.
The Ream Award is selected based on high quality research with an empha-
sis on randomized clinical trials with significant scientific impact. The winning
manuscript for 2006 certainly meets these criteria. This year, the award is pre-
sented to Castaño et al1 for their manuscript entitled, “Effects of Combination
Treatment with Policosanol and Omega-3 Fatty Acids on Platelet Aggregation: 
A Randomized, Double-Blind Clinical Study.”
Policosanol has been evaluated as a possible alternative or supplement to
currently available lipid-lowering medications. Several studies2,3 have reported
significant lipid-lowering benefits that compare favorably to statins, sterols,
and stanols. However, a randomized controlled trial4 of 143 patients did not
demonstrate any differences in lipid lowering between policosanol and placebo.
In addition, studies5,6 have shown policosanol to have clinically relevant effects
on platelet aggregation.
The authors of this manuscript designed a study to evaluate the effect of
policosanol on platelet aggregation and lipid levels. In addition to the important
clinical implications of the study objectives, the clear and careful attention to
study design and methodology was an important factor in the decision to pres-
ent the authors with the Ream Award.
Several key areas of study design were described in sufficient detail to
allow the reader to determine that the study was appropriately designed and
powered to show clinically relevant differences in the treatment groups. The
authors provided sufficient background information to detail the clinical
importance of the study and the available literature on the topic. Clear docu-
mentation of ethical review approval and informed written consent from all
participants was provided. The outcome variables were clearly detailed
along with the inclusion and exclusion criteria applied to all potential partici-
pants. In addition, the authors clearly documented how safety and tolerabili-
ty were monitored and recorded. Finally, the authors objectively discussed
the limitations of this study and the need for further studies to determine if
policosanol should be included as an alternative or supplemental therapeu-
tic option.
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The editorial board of Current Therapeutic Research is proud to present the
authors of this manuscript with the seventh Charles R. Ream, MD, Award for
Excellence. We look forward to another year of submissions from these and
other authors, and we hope that the journal will continue to receive high quali-
ty manuscripts in the coming year.
Judd L. Walson, MD, MPH
Editor-in-Chief
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